Sergey Glagolev, the Deputy Minister of Health of the Russian Federation, recently announced that in the last ten months, approximately 40% of the registered products have been developed by domestic manufacturers. He proposed adopting a fresh perspective on Russian medical products to bolster confidence in those produced in the Russian Federation.
The registered products encompass cutting-edge medical technologies, including DNA sequencing software, coronary vessel stents, diagnostic systems for identifying epidemiologically significant infections, and advanced surgical navigation systems. The Deputy Minister highlighted a commitment to backing Russian advancements through 2030, expressing optimism that these efforts will bolster the nation’s technological sovereignty and secure lasting independence in crucial medical sectors.
